欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0521/001
药品名称Optinate Once a Week
活性成分
    • risedronate 35.0 mg
剂型Film-coated tablet
上市许可持有人Actavis Group PTC ehf Reykjavikurvegi 76-78 220 Hafnarfjordur Iceland Splitting of procedure - SE/H/194/003&005/MR (old procedure number) to IE/H/521/001-002/MR (new procedure number)
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    许可日期2017/08/09
    最近更新日期2020/04/07
    药物ATC编码
      • M05BA07 risedronic acid
    申请类型
    • TypeLevel1:[not specified]
    • TypeLevel2:[not specified]
    • TypeLevel3:[not specified]
    • TypeLevel4:[not specified]
    • TypeLevel5:[not specified]
    附件文件下载
      市场状态Withdrawn(注:已撤市)
      ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase